RECOMBINANT MVA VIRUSES FOR INTRATUMORAL AND/OR INTRAVENOUS ADMINISTRATION FOR TREATING… Application WO-2021099586-A1 World Intellectual Property Organisation (WIPO) 27 May 2021
MEDICAL USES OF 4-1BBL ADJUVANTED RECOMBINANT MODIFIED VACCINIA VIRUS ANKARA (MVA) Application WO-2021099572-A1 World Intellectual Property Organisation (WIPO) 27 May 2021